Anticancer Effects of Garlic and Garlic-derived Compounds for Breast Cancer Control
Authors: Tsubura, Airo; Lai, Yen-Chang; Kuwata, Maki; Uehara, Norihisa; Yoshizawa, Katsuhiko
Source: Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Volume 11, Number 3, March 2011 , pp. 249-253(5)
Publisher: Bentham Science Publishers
Abstract:Garlic and garlic-derived compounds reduce the development of mammary cancer in animals and suppress the growth of human breast cancer cells in culture. Oil-soluble compounds derived from garlic, such as diallyl disulfide (DADS), are more effective than water-soluble compounds in suppressing breast cancer. Mechanisms of action include the activation of metabolizing enzymes that detoxify carcinogens, the suppression of DNA adduct formation, the inhibition of the production of reactive oxygen species, the regulation of cell-cycle arrest and the induction of apoptosis. Selenium-enriched garlic or organoselenium compounds provide more potent protection against mammary carcinogenesis in rats and greater inhibition of breast cancer cells in culture than natural garlic or the respective organosulfur analogues. DADS synergizes the effect of eicosapentaenoic acid, a breast cancer suppressor, and antagonizes the effect of linoleic acid, a breast cancer enhancer. Moreover, garlic extract reduces the side effects caused by anti-cancer agents. Thus, garlic and garlic-derived compounds are promising candidates for breast cancer control.
Keywords: 7,12-dimethylbenz anthracene (DMBA); Allicin; DADS; Diallyl trisulfide; Garlic; N-methyl-Nnitrosourea (MNU); ORGANOSULFUR COMPOUNDS; SELENIUM-ENRICHED GARLIC; apoptosis; breast; diallyl disulfide (DADS); diallyl selenide (DASe); mammary; selenium; seleniummethylselenocysteine (SeMSC)
Document Type: Research Article
Publication date: 2011-03-01